A phase II study combining bendamustine and obinutuzumab showed promising results in patients with previously untreated chronic lymphocytic leukemia (CLL). Dr. Jeff Sharman, the director of research at WVCI and the medical director of hematology research for The US Oncology Network, discussed the results of the GIBB trial at the 2017 American Society of Hematology.
When Bob Petit gazes through his camera lens, he sees wonder and beauty. Calling himself a “serious amateur,” his love of photography has grown over the years. Yet, not even with the clearest of lenses, could Bob have seen his cancer diagnosis coming. “I had a feeling something was wrong, because I was sleeping 14 hours a day,” Bob says. “But I didn’t think about cancer.”.
Clinical trials are the centerpiece for the drug-testing system in the United States. Each cancer study conducted tries to answer scientific questions and determine better ways to prevent, diagnose or treat the disease. As researchers test the effectiveness of trial drugs, patients who participate, in many cases, benefit from life-saving treatment options years before they.